230 related articles for article (PubMed ID: 17018584)
41. Oncogene transformation and the metastatic phenotype.
Chambers AF; Tuck AB
Anticancer Res; 1988; 8(5A):861-71. PubMed ID: 3052258
[TBL] [Abstract][Full Text] [Related]
42. Rb and N-ras function together to control differentiation in the mouse.
Takahashi C; Bronson RT; Socolovsky M; Contreras B; Lee KY; Jacks T; Noda M; Kucherlapati R; Ewen ME
Mol Cell Biol; 2003 Aug; 23(15):5256-68. PubMed ID: 12861012
[TBL] [Abstract][Full Text] [Related]
43. K-ras is essential for the development of the mouse embryo.
Koera K; Nakamura K; Nakao K; Miyoshi J; Toyoshima K; Hatta T; Otani H; Aiba A; Katsuki M
Oncogene; 1997 Sep; 15(10):1151-9. PubMed ID: 9294608
[TBL] [Abstract][Full Text] [Related]
44. ras proteins: biological effects and biochemical targets (review).
Bar-Sagi D
Anticancer Res; 1989; 9(5):1427-37. PubMed ID: 2686537
[TBL] [Abstract][Full Text] [Related]
45. Functional analysis and secondary expression profiling of candidate genes deregulated in conjunction with oncogenic Ras signaling.
Raudies O; Kuban RJ; Hamacher F; Klein-Hitpass L; Tchernitsa OI; Sers C; Herzel HP; Schäfer R
Adv Enzyme Regul; 2005; 45():63-84. PubMed ID: 16023704
[No Abstract] [Full Text] [Related]
46. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
[TBL] [Abstract][Full Text] [Related]
47. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
48. The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle transition in C. elegans.
Ouellet J; Roy R
BMC Dev Biol; 2007 Apr; 7():38. PubMed ID: 17466069
[TBL] [Abstract][Full Text] [Related]
49. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.
Matoso A; Zhou Z; Hayama R; Flesken-Nikitin A; Nikitin AY
Carcinogenesis; 2008 Mar; 29(3):620-8. PubMed ID: 17893233
[TBL] [Abstract][Full Text] [Related]
50. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
51. Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development.
Ferguson KL; Vanderluit JL; Hébert JM; McIntosh WC; Tibbo E; MacLaurin JG; Park DS; Wallace VA; Vooijs M; McConnell SK; Slack RS
EMBO J; 2002 Jul; 21(13):3337-46. PubMed ID: 12093735
[TBL] [Abstract][Full Text] [Related]
52. Role of the retinoblastoma tumor suppressor protein in cellular differentiation.
Nguyen DX; McCance DJ
J Cell Biochem; 2005 Apr; 94(5):870-9. PubMed ID: 15669057
[TBL] [Abstract][Full Text] [Related]
53. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
54. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
55. Regulation of cell lineage specification by the retinoblastoma tumor suppressor.
Skapek SX; Pan YR; Lee EY
Oncogene; 2006 Aug; 25(38):5268-76. PubMed ID: 16936747
[TBL] [Abstract][Full Text] [Related]
56. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
57. Differential effects of c-Ras upon transformation, adipocytic differentiation, and apoptosis mediated by the simian virus 40 large tumor antigen.
Cao J; Arulanandam R; Vultur A; Anagnostopoulou A; Raptis L
Biochem Cell Biol; 2007 Feb; 85(1):32-48. PubMed ID: 17464343
[TBL] [Abstract][Full Text] [Related]
58. Retinoblastoma gene family expression in lymphoid tissues.
Leoncini L; Bellan C; De Falco G
Oncogene; 2006 Aug; 25(38):5309-14. PubMed ID: 16936752
[TBL] [Abstract][Full Text] [Related]
59. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
[TBL] [Abstract][Full Text] [Related]
60. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses.
Szekely L; Jiang WQ; Bulic-Jakus F; Rosen A; Ringertz N; Klein G; Wiman KG
Cell Growth Differ; 1992 Mar; 3(3):149-56. PubMed ID: 1633106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
